Hydroxychloroquine Treatment of Rheumatoid Arthritis Lowered Risk of Nonalcoholic Fatty Liver Disease

This new research presented at ACR Convergence 2023 led to several notable findings for patients with rheumatoid arthritis.

Related Keywords

Veterans Hospital ,Kao Hsiung ,Taiwan ,Hsin Hua Chen ,Tainan Municipality ,Chiayi ,Jiayi Shi ,United States ,American , ,Chiayi Branch ,Drug Administration ,American Liver Foundation ,American College Of Rheumatology ,Taiwan National Health Insurance Research Database ,American College ,Taichung Veterans General Hospital ,National Health Insurance Research Database ,Oliver Think ,Taichung Veterans Hospital ,Taichung General Veterans ,Decreased Risk ,Non Alcoholic Fatty Liver Disease ,Rheumatoid Arthritis ,Cohort Study ,Accessed November ,Finds Hydroxychloroquine Lowers Risk ,Nonalcoholic Fatty Liver Disease ,Fatty Liver Disease ,Racr ,Hydroxychloroquine ,